News

Drugmakers seek FDA emergency authorization for molnupiravir, antiviral pill to treat COVID-19: Latest updates

Merck & Co. and Ridgeback Biotherapeutics announced Monday the submission of emergency use authorization to the FDA for molnupiravir. COVID updates.